Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nelson L Michael

Showing results (301-310 of 372) with videos related to

Pageof 38
Sort By:
Plos One|October 3, 2013
Plasma IgG to linear epitopes in the V2 and V3 regions of HIV-1 gp120 correlate with a reduced risk of infection in the RV144 vaccine efficacy trialRaphael Gottardo, Robert T Bailer, Bette T Korber, et al.
Vaccine|May 31, 2011
International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populationsDan H Barouch, Sandra V Kik, Gerrit J Weverling, et al.
Plos Pathogens|February 25, 2017
Boosting of HIV envelope CD4 binding site antibodies with long variable heavy third complementarity determining region in the randomized double blind RV305 HIV-1 vaccine trialDavid Easterhoff, M Anthony Moody, Daniela Fera, et al.
Cell Host & Microbe|March 4, 2021
B cell engagement with HIV-1 founder virus envelope predicts development of broadly neutralizing antibodiesSamantha M Townsley, Gina C Donofrio, Ningbo Jian, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 2, 2024
Clinical, molecular, and drug resistance epidemiology of HIV in Jordan, 2019-2021: A national studyFaris G Bakri, Heyam H Mukattash, Hiam Esmeiran, et al.
Science Translational Medicine|July 17, 2015
HLA class II genes modulate vaccine-induced antibody responses to affect HIV-1 acquisitionHeather A Prentice, Georgia D Tomaras, Daniel E Geraghty, et al.
Journal of Virology|May 15, 2015
Comparable Antigenicity and Immunogenicity of Oligomeric Forms of a Novel, Acute HIV-1 Subtype C gp145 Envelope for Use in Preclinical and Clinical Vaccine ResearchLindsay Wieczorek, Shelly J Krebs, Vaniambadi Kalyanaraman, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2024
Single-cell analyses reveal that monocyte gene expression profiles influence HIV-1 reservoir size in acutely treated cohortsPhilip K Ehrenberg, Aviva Geretz, Meta Volcic, et al.
Journal of Virology|July 3, 2023
Targeting the Spike Receptor Binding Domain Class V Cryptic Epitope by an Antibody with Pan-Sarbecovirus ActivityJaime L Jensen, Rajeshwer S Sankhala, Vincent Dussupt, et al.
Nature Communications|May 29, 2025
Single-cell analyses identify monocyte gene expression profiles that influence HIV-1 reservoir size in acutely treated cohortsPhilip K Ehrenberg, Aviva Geretz, Meta Volcic, et al.
Pageof 38

Showing results (301-310 of 372) with videos related to

Sort By:
Pageof 38
Plos One|October 3, 2013
Plasma IgG to linear epitopes in the V2 and V3 regions of HIV-1 gp120 correlate with a reduced risk of infection in the RV144 vaccine efficacy trialRaphael Gottardo, Robert T Bailer, Bette T Korber, et al.
Vaccine|May 31, 2011
International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populationsDan H Barouch, Sandra V Kik, Gerrit J Weverling, et al.
Plos Pathogens|February 25, 2017
Boosting of HIV envelope CD4 binding site antibodies with long variable heavy third complementarity determining region in the randomized double blind RV305 HIV-1 vaccine trialDavid Easterhoff, M Anthony Moody, Daniela Fera, et al.
Cell Host & Microbe|March 4, 2021
B cell engagement with HIV-1 founder virus envelope predicts development of broadly neutralizing antibodiesSamantha M Townsley, Gina C Donofrio, Ningbo Jian, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 2, 2024
Clinical, molecular, and drug resistance epidemiology of HIV in Jordan, 2019-2021: A national studyFaris G Bakri, Heyam H Mukattash, Hiam Esmeiran, et al.
Science Translational Medicine|July 17, 2015
HLA class II genes modulate vaccine-induced antibody responses to affect HIV-1 acquisitionHeather A Prentice, Georgia D Tomaras, Daniel E Geraghty, et al.
Journal of Virology|May 15, 2015
Comparable Antigenicity and Immunogenicity of Oligomeric Forms of a Novel, Acute HIV-1 Subtype C gp145 Envelope for Use in Preclinical and Clinical Vaccine ResearchLindsay Wieczorek, Shelly J Krebs, Vaniambadi Kalyanaraman, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2024
Single-cell analyses reveal that monocyte gene expression profiles influence HIV-1 reservoir size in acutely treated cohortsPhilip K Ehrenberg, Aviva Geretz, Meta Volcic, et al.
Journal of Virology|July 3, 2023
Targeting the Spike Receptor Binding Domain Class V Cryptic Epitope by an Antibody with Pan-Sarbecovirus ActivityJaime L Jensen, Rajeshwer S Sankhala, Vincent Dussupt, et al.
Nature Communications|May 29, 2025
Single-cell analyses identify monocyte gene expression profiles that influence HIV-1 reservoir size in acutely treated cohortsPhilip K Ehrenberg, Aviva Geretz, Meta Volcic, et al.
Pageof 38